0001104659-18-058108.txt : 20180924
0001104659-18-058108.hdr.sgml : 20180924
20180924085811
ACCESSION NUMBER: 0001104659-18-058108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180920
FILED AS OF DATE: 20180924
DATE AS OF CHANGE: 20180924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heberlig Chris
CENTRAL INDEX KEY: 0001532217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 181082711
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
a4.xml
4
X0306
4
2018-09-20
0
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001532217
Heberlig Chris
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM11
BERMUDA
0
1
0
0
EVP & CFO
Share Option
30.93
2018-09-20
4
A
0
45000
0
A
2028-09-19
Class A Common Shares
45000
45000
D
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter. The vesting commencement date is September 20, 2018.
/s/ Thomas W. Beetham, Attorney-in-Fact For Chris Heberlig
2018-09-24